Medical Patent Law Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Depomed

Depomed announced its latest developments

This trend article is an immediate alert from NewsRx to identify the most recent news developments at Depomed.

Report 1: Depomed, Inc. (DEPO) announced a favorable Markman decision by Judge Charles Breyer of the United States District Court for the Northern District of California in Depomed's patent infringement case against Ivax Corporation.

Depomed sued Ivax for infringement of U.S. Patent Nos. 6,340,475 and 6,635,280 by Ivax's extended release metformin hydrochloride tablets. The patents are held by Depomed and relate to the company's AcuForm drug delivery technology. Depomed's...

• View Other Issues of Medical Patent Law Weekly
  
• View Other NewsRx Publications